| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Normal phase POSITIVE ION MODE | KA-013 | Treatment:25 nM LGK974 | area |
| Normal phase POSITIVE ION MODE | KA-014 | Treatment:25 nM LGK974 | area |
| Normal phase POSITIVE ION MODE | KA-016 | Treatment:25 nM LGK974 | area |
| Normal phase POSITIVE ION MODE | KA-010 | Treatment:Control | area |
| Normal phase POSITIVE ION MODE | KA-011 | Treatment:Control | area |
| Normal phase POSITIVE ION MODE | KA-012 | Treatment:Control | area |
| Normal phase NEGATIVE ION MODE | KA-013 | Treatment:25 nM LGK974 | area |
| Normal phase NEGATIVE ION MODE | KA-014 | Treatment:25 nM LGK974 | area |
| Normal phase NEGATIVE ION MODE | KA-016 | Treatment:25 nM LGK974 | area |
| Normal phase NEGATIVE ION MODE | KA-010 | Treatment:Control | area |
| Normal phase NEGATIVE ION MODE | KA-011 | Treatment:Control | area |
| Normal phase NEGATIVE ION MODE | KA-012 | Treatment:Control | area |
Return to study ST001902 main page
Download data matrix(Metabolomics analysis of AsPC-1 PDAC cells treated with Porcupine inhibitor (LGK974) Normal phase POSITIVE ION MODE)
Download data matrix(Metabolomics analysis of AsPC-1 PDAC cells treated with Porcupine inhibitor (LGK974) Normal phase NEGATIVE ION MODE)
- Metabolomics Workbench
|